NCT03255460

Brief Summary

Multiple sclerosis (MS) is a chronic, progressive and unpredictable disease of the central nervous system. In MS, various loss of strength, balance and gait disturbances arise in the central nervous system due to sensory and/or motor neuron degeneration. These disorders lead to limitations in individual activities and participation. Fatigue is as reported one of the most common first three symptoms among patients with MS and affects up to 80% of the patients. Fatigue is defined as the lack of physical and/or mental energy. Sometimes fatigue can reduce the quality of life by leaving other disorders behind. The most important effect of fatigue is that individuals reduce their physical activity levels. This can lead to the inactivity-related secondary problems being added to the findings of the disease. So the physical capacities of individuals may gradually decrease. In the literature, there are many studies showing that the level of physical activity of individuals with MS is lower than in healthy individuals. When the investigators analyze the studies that investigate the relation between fatigue and physical activity levels, it is seen that there is the single study about this subject in the literature. As a result, additional studies are needed to investigate the level of physical activity and the factors affecting it in individuals with MS. Therefore, the investigators planned this study to investigate the relationship between fatigue and physical activity levels in patients with MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 21, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2018

Completed
Last Updated

April 2, 2021

Status Verified

March 1, 2021

Enrollment Period

1.3 years

First QC Date

August 12, 2017

Last Update Submit

March 31, 2021

Conditions

Keywords

Multiple SclerosisFatiguePhysical ActivityExercise

Outcome Measures

Primary Outcomes (4)

  • Fatigue severity

    Fatigue Severity Scale

    Five minutes

  • Fatigue

    Fatigue Impact Scale

    Eight minutes

  • Physical activity behavior

    Evaluated using an ActiGraph (GT3X+)

    Three days

  • Physical activity

    International Physical Activity Questionnaire

    Five minutes

Secondary Outcomes (4)

  • Functional exercise capacity

    Fifteen minutes

  • Balance

    Fifteen minutes

  • Functional Mobility

    Two minutes

  • Muscle strength

    Fifteen minutes

Study Arms (2)

Multiple Sclerosis individuals

Multiple sclerosis patients included in this study. Inclusion and exclusion criteria were considered.

Healthy individuals

Those without chronic disease were included in the study. Inclusion and exclusion criteria were considered.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Power analysis was performed using "G \* Powerversion3.1 program" in order to determine the minimum number of subjects to be taken into operation. Accordingly, the number of participants in the study group (n) = 37 (α: 0.05, for power 80%) and in the control group (n) = 37).

You may qualify if:

  • years of age
  • Having a diagnosis of "Multiple Sclerosis" by a specialist physician
  • Relapse free in the last 3 mounts
  • Having an ambulatory status (Expanded Disability Status Scale score ≤ 6 )
  • No diagnosis of depression

You may not qualify if:

  • Any cardiovascular, orthopedic, visual, hearing and perception problems that may affect the results of the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Ankara, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Multiple SclerosisFatigueMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Kader Çekim, Pt

    Research assistant

    STUDY CHAIR
  • Arzu Güçlü Gündüz, Pt, Phd

    Associate professor

    STUDY DIRECTOR
  • Ceyla İrkeç, MD, Prof

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Asisstant

Study Record Dates

First Submitted

August 12, 2017

First Posted

August 21, 2017

Study Start

March 27, 2017

Primary Completion

July 4, 2018

Study Completion

July 4, 2018

Last Updated

April 2, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared

Locations